RGEN (STOCKS)
Repligen Corp
$167.490000
+1.790000 (+1.08%)
Prev close: $165.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Olivier Dominique Loeillot
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,654.00M
- Employees
- 1,778
- P/E (TTM)
- 225.84
- P/B (TTM)
- 4.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $785.10M |
| Benefits Costs and Expenses | $732.95M |
| Cost Of Revenue | $362.43M |
| Costs And Expenses | $720.49M |
| Gross Profit | $422.67M |
| Nonoperating Income/Loss | -$12.46M |
| Operating Expenses | $358.06M |
| Selling, General, and Administrative Expenses | $301.18M |
| Depreciation and Amortization | $78.78M |
| Research and Development | $56.17M |
| Operating Income/Loss | $64.61M |
| Income/Loss From Continuing Operations After Tax | $41.54M |
| Income/Loss From Continuing Operations Before Tax | $52.15M |
| Income Tax Expense/Benefit | $10.61M |
| Income Tax Expense/Benefit, Deferred | -$5.58M |
| Net Income/Loss | $41.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $41.54M |
| Net Income/Loss Available To Common Stockholders, Basic | $41.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.75 |
| Diluted Earnings Per Share | $0.73 |
| Basic Average Shares | 56,443,291 |
| Diluted Average Shares | 56,717,573 |
| Assets | $2.95B |
| Current Assets | $1.20B |
| Inventory | $186.60M |
| Other Current Assets | $1.01B |
| Noncurrent Assets | $1.75B |
| Fixed Assets | $167.51M |
| Intangible Assets | $357.62M |
| Other Non-current Assets | $1.22B |
| Liabilities | $838.15M |
| Current Liabilities | $132.66M |
| Accounts Payable | $33.23M |
| Wages | $31.20M |
| Other Current Liabilities | $68.22M |
| Noncurrent Liabilities | $705.49M |
| Long-term Debt | $551.05M |
| Other Non-current Liabilities | $154.45M |
| Equity | $2.11B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.11B |
| Liabilities And Equity | $2.95B |
| Net Cash Flow From Operating Activities | $134.86M |
| Net Cash Flow From Operating Activities, Continuing | $134.86M |
| Net Cash Flow From Investing Activities | -$222.60M |
| Net Cash Flow From Investing Activities, Continuing | -$222.60M |
| Net Cash Flow From Financing Activities | -$11.79M |
| Net Cash Flow From Financing Activities, Continuing | -$11.79M |
| Net Cash Flow | -$99.53M |
| Net Cash Flow, Continuing | -$99.53M |
| Comprehensive Income/Loss | $23.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $23.47M |
| Other Comprehensive Income/Loss | -$25.43M |